ME
Mark Elliott Boulding sold $12K of PTCT stock
Mark Elliott Boulding, Exec. VP And Clo of Ptc Therapeutics, Inc. (PTCT), sold 192 shares of PTCT stock worth $12K, per an SEC Form 4 filed Oct 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 9, 2026, 4 days before it was made public.
PTCT has moved -2.1% since the trade date, from $64.70 to $63.36 (Nov 12, 2026 close).
- Traded
- Oct 9, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 4 days
- Price since
- -2.1%
- Role
- Exec. VP And Clo
- Source
- SEC Form 4